Neuroscience Trials Australia
Established in 2001, Neuroscience Trials Australia (NTA) is a world-class clinical trials partner who specialises in managing neuroscience-related clinical trials from early through to phase III and IV.
As a key service linked to The Florey, NTA is provides direct access to therapeutic expertise, key opinion leaders and clinical trial sites. We also support coordination of research and development with clinical practice.
NTA works with both local and international partners including biotech companies, device manufacturers, pharmaceutical companies, and clinical researchers in both universities and hospitals.
NTA has extensive clinical research knowledge in feasibility, start-up, initiation, patient recruitment, biostatistics and IP management – working across multiple regions globally and are experts in managing Australian clinical trials, from start up through to publication. We have unique neurological expertise, conducting clinical trials in:
- neurological diseases, such as Alzheimer’s and Parkinson’s disease
- pain, nociceptive and neuropathic
- amyotrophic lateral sclerosis
- depression, major depressive disorder, unspecified depression
- pain, cancer, post-operative, musculoskeletal, arthritis
- multiple sclerosis
- anxiety, unspecified
- Huntington’s disease
- traumatic brain injury